Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips introduces next-generation enterprise imaging solution to connect every step of the patient journey at RSNA 2019

One millionth procedure carried out on Philips Azurion advanced image-guided therapy platform

Philips announces WE-TRUST multicenter clinical trial to assess impact of ‘Direct to Angio Suite’ workflow on stroke patient outcomes

Philips wins IP infringement disputes with power toothbrush and brush head manufacturers and sellers

Koninklijke Philips: Hard To Pronounce But Lets You Sleep At Night

Philips employees and Philips Foundation join forces in the fight on childhood pneumonia

Philips announces first installation of IntelliSpace Critical Care and Anesthesia system at Kasih Ibu Hospital in Bali, Indonesia

Philips launches its first clinical product for aiding cognitive assessment in the U.S.

Philips and Sunrise Senior Living introduce next generation senior care technology for residents at Welltower’s flagship Manhattan community

Philips launches next-generation vital signs monitor for early patient intervention in general care setting

Research from Philips highlights the need for radiology staff empowerment and workflow-focused innovation

Electronics giant Philips accuses a Seattle-area medical device repair and service company of hacking into its imaging machines and stealing trade secrets in a lawsuit filed this week, pitting the Netherlands-based corporation against a 13-year-old startup.

Lawsuit: Electronics giant Philips accuses Seattle-area company of hacking its medical devices

Koninklijke Philips' (PHG) third-quarter results reflect robust performance in the Diagnosis & Treatment business despite negative impact from tariffs.

Koninklijke Philips' (PHG) Q3 Earnings & Sales Rise Y/Y

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q3 2019 Results - Earnings Call Transcript

October 28, 2019     Third-quarter highlights

Philips delivers Q3 sales of EUR 4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of 12.4%

Philips and Klinikum Stuttgart hospital sign 10-year innovation partnership agreement

Phillips (PHG) bolsters presence in Diagnosis & Treatment business with new low-dose drug-coated balloons.

Philips Boosts Stellarex Portfolio, Expands in Healthcare

Philips (PHG) and Spencer's joint digital solution, which improves medication adherence in patients in the United States, is set to hit select European markets.

Philips & Spencer Health to Extend Joint Solution to Europe

Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients

Philips and Spencer Health Solutions expand partnership to Europe

Shares of Philips Electronics PHIA, -8.33% tumbled 8% in early Amsterdam as the company issued a warning over its connected care business, which had a 4.5-point decline in its adjusted margin during the third quarter.

Philips shares slump as connected-care business hit by tariffs

Philips provides update on its financial performance in Q3 2019

Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon

Amsterdam, the Netherlands and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its commitment to improving care for hundreds of millions of patients worldwide living with chronic sleep and respiratory conditions in its 17th appearance at the European Respiratory Society (ERS) International Congress, taking place September 28 - October 2, 2019, in Madrid, Spain.

Philips showcases commitment to improving respiratory care at ERS 2019

Philips announces availability of expanded SmartSleep suite of solutions in U.S. market

News for Royal Philips Stock (PHG)